Aquinox Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AQXP and buy or sell other stocks, ETFs, and their options commission-free!About AQXP
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
CEORachel L. McMinn, PhD
CEORachel L. McMinn, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees—
Employees—
AQXP Key Statistics
Market cap302.52M
Market cap302.52M
Price-Earnings ratio-4.41
Price-Earnings ratio-4.41
Dividend yield—
Dividend yield—
Average volume194.90K
Average volume194.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$37.27
52 Week high$37.27
52 Week low$6.88
52 Week low$6.88
Stock Snapshot
As of today, Aquinox Pharmaceuticals(AQXP) shares are valued at $10.63. The company's market cap stands at 302.52M, with a P/E ratio of -4.41.
On 2025-12-17, Aquinox Pharmaceuticals(AQXP) stock opened at —, reached a high of —, and a low of —.
The Aquinox Pharmaceuticals(AQXP)'s current trading volume is 0, compared to an average daily volume of 194.9K.
During the past year, Aquinox Pharmaceuticals(AQXP) stock moved between $6.88 at its lowest and $37.27 at its peak.
During the past year, Aquinox Pharmaceuticals(AQXP) stock moved between $6.88 at its lowest and $37.27 at its peak.